Synthesis, Characterisation and Anticancer Study of Acridine derivatives

Authors

  • Herole R A Department of Pharmaceutical Chemistry, Institute of Pharmacy, Shri. Jagdish Prasad Jhabarmal Tibrewala University, Vidyanagri, Jhunjhunu, Rajasthan-333001
  • Rakesh Kumar Jat Department of Pharmaceutical Chemistry, Institute of Pharmacy, Shri. Jagdish Prasad Jhabarmal Tibrewala University, Vidyanagri, Jhunjhunu, Rajasthan-333001

DOI:

https://doi.org/10.61280/tjpls.v10i5.146

Keywords:

Acridine, MTT assay, Anticancer activity, Anticancer drugs

Abstract

Cancer is one of the global problem and a major cause for mortality. many treatment strategies are available for cancer treatment, still there is a scope for novel treatment to avoid serious side effects of existing therapy. Novel DNA binding agents are needed for effective treatment of cancers. In the field of antitumor DNA-intercalating agents, 9-aminoacridines play an important role due to their antiproliferative properties. Several cancer chemotherapeutics such as amsacrine and nitracrine have been developed as anticancer agents.In present study, a series of new acridine-based derivatives numbered 3a–3j were synthesized and their anticancer activity against A549 (Human, small cell Lung Carcinoma) cell line was evaluated by MTT Assay. Out of the screened compounds, compound 3b exhibited potent anticancer activity with IC50 78.04 µg/ml for lung cancer cell (A-549) line.Further in vivo study of newly synthesized acridine derivative can explore a ray of light in the field of anticancer drugs.

Downloads

Download data is not yet available.

References

I. Kumler, N. Brunner, J. Stenvang, E. Balslev, D.L. Nielsen, A systematic review on

Topoisomerase-I inhibition in the treatment of metastatic breast cancer, Breast Cancer Res.

Treat. 138 (2013), 347–358.

X. Zhang, B. Bao, X.H. Yu, et al., The discovery and optimization of novel dual inhibitors

of topoisomerase II and histone deacetylase, Bioorg. Med. Chem. 21 (2013) 6981–6995.

S.M.B. Nijman, S.H. Friend, Cancer. Potential of the synthetic lethality principle, Science

(2013), 809–811.

Y. Li, H.B. Zhang, W.L. Huang, X. Zhen, Y.M. Li, Synthesis and biological evaluation of

tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in

cancer,Chin. Chem. Lett. 19 (2008) 169–171.

L.H. Shen, Y. Li, D.H. Zhang, Y.S. Lai, L.J. Liu, Synthesis and evaluation of nitrate

derivatives of colchicine as anticancer agents, Chin. Chem. Lett. 22 (2011) 768– 770.

C. Kaplan-Ozen, B. Tekiner-Gulbas, E. Foto, et al., Benzothiazole derivatives as human

DNAtopoisomerase II alpha inhibitors, Med. Chem. Res. 22 (2013) 5798– 5808.

Z.Y. Tian, H.X. Ma, S.Q. Xie, et al., Synthesis, DNA binding and topoisomerase inhibition

of mononaphthalimide homospermidine derivatives, Chin. Chem. Lett. 19 (2008) 509–512.

J.R. Goodell, A.V. Ougolkov, H. Hiasa, et al., Acridine-based agents with topoisomerase II

activity inhibit pancreatic cancer cell proliferation and induce apoptosis, J. Med. Chem. 51

(2012) 179–182.

K. Padget, A. Stewart, P. Charlton, M.J. Tilby, C.A. Austin, An investigation into the

formation of N-2-(dimethylamino)ethyl acridine-4-carboxamide (DACA) and 6- 2-

(dimethylamino) ethylamino-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride

(TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia

cells, Biochem. Pharmacol. 60 (2000) 817–821

J.Y. Chang, C.F. Lin, W.Y. Pan, et al., New analogues of AHMA as potential antitumor

agents: synthesis and biological activity, Bioorg. Med. Chem. 11 (2003) 4959–4969

K. Rastogi, J.Y. Chang, W.Y. Pan, et al., Antitumor AHMA linked to DNA minor groove

binding agents: synthesis and biological evaluation, J. Med. Chem. 45 (2002) 4485–4493.

R. Zittoun, m-AMSA: a review of clinical data, Eur. J. Cancer Clin. Oncol. 21 (1985)

–653.

T.L. Su, T.C. Chou, J.Y. Kim, et al., 9-Substituted acridine-derivatives with long half-life

and potent antitumor-activity-synthesis and structure–activity-relationships, J. Med.

Chem. 38 (1995) 3226–3235.

I. Gonzalez-Sanchez, J.D. Solano, M.A. Loza-Mejia, et al., Antineoplastic activity of the

thiazolo 5, 4-b quinoline derivative D3CLP in K-562 cells is mediated through effector

caspases activation, Eur. J. Med. Chem. 46 (2011) 2102–2108.

C.H. Chen, Y.W. Lin, X.G. Zhang, et al., Synthesis and in vitro cytotoxicity of 9-

anilinoacridines bearing N-mustard residue on both anilino and acridine rings, Eur. J.

Med. Chem. 44 (2009) 3056–3059.

X.D. Luan, C.M. Gao, N.N. Zhang, et al., Exploration of acridine scaffold as a potentially

interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase

inhibitors, Bioorg. Med. Chem.19 (2011) 3312– 3319

Y.Q. Li, C.Y. Tan, C.M. Gao, et al., Discovery of benzimidazole derivatives as novel

multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors, Bioorg. Med. Chem. 19

(2011) 4529–4535.

X.L. Lang, L.L. Li, Y.Z. Chen, et al., Novel synthetic acridine derivatives as potent DNA-

binding and apoptosis-inducing antitumor agents, Bioorg. Med. Chem. 21 (2013) 4170–

X.L. Lang, Q.S. Sun, Y.Z. Chen, et al., Novel synthetic 9-benzyloxyacridine analogue as

both tyrosine kinase and topoisomerase I inhibitor, Chin. Chem. Lett. 24 (2013) 677–680.

C.M. Gao, F. Liu, X.D. Luan, et al., Novel synthetic 2-amino-10-(3, 5-dimethoxy)

benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents,

Bioorg. Med. Chem. 18 (2010) 7507–7514.

C.M. Gao, S.F. Li, X.L. Lang, et al., Synthesis and evaluation of 10-(3, 5-

dimethoxy)benzyl-9(10H)- acridone derivatives as selective telomeric G-quadruplex

DNA ligands, Tetrahedron 68 (2012) 7920–7925.

X.D. Luan, C.M. Gao, Q.S. Sun, et al., Novel synthetic azaacridine analogues as

Topoisomerase-I inhibitors, Chem. Lett. 40 (2011) 728–729.

X.L. Lang, X.D. Luan, C.M. Gao, Y.Y. Jiang, Recent progress of acridine derivatives with

antitumor activity, Prog. Chem. 24 (2012) 1497–1505.

Published

17-09-2023

How to Cite

Herole R A, and Rakesh Kumar Jat. “Synthesis, Characterisation and Anticancer Study of Acridine Derivatives”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 10, no. 5, Sept. 2023, pp. 50-56, doi:10.61280/tjpls.v10i5.146.
Statistics
195 Views | Downloads

Issue

Section

Research Article